 中文摘要 
 
位於毛髮、皮膚以及眼睛部位之黑色素形成過程中，酪胺酸酶被視為其合成的第一個速
率限制步驟的酵素；酪胺酸酶的活性取決於活性部位上結合的兩個銅離子。故此，螯合銅離
子即可抑制酪胺酸酶活性。近來，酪胺酸酶抑制劑在醫療藥物上的使用以及化粧品產業之應
用愈趨重要，目前有許多運用抑制黑色素形成的藥劑來針對皮膚色素沉澱以及色素異常的疾
病，而酪胺酸酶抑制劑是一種主要治療過度色素沉澱的有效藥物 (科學界目前仍以蘑菇酪胺
酸酶為探討模式)。天然萃取物首先研究於抑制磨菇酪胺酸酶活性，進而影響黑色素形成過
程，直到抑制整個黑色素生成。為了研發新的目標蛋白(人類酪胺酸酶)抑制劑，我們從電腦
模擬程式，辨認出可能有抑制酵素效果的三維結構圖，我們也同時分析研究人體纖維母細胞，
來評估抑制劑對於細胞存活率的影響。 
 
關鍵詞：酪胺酸酶，黑色素細胞，結構，銅離子，抑制與機轉 
 
 
 
 
Abstract 
 
Tyrosinases are known to be the first rate-limiting enzymes in the synthesis of melanin 
pigments responsible for coloring hair, skin and eyes. Tyrosinase activity depends on the binding 
and function of two copper ions at the active site. Therefore, chelating copper inhibits the activity 
tyrosinase. Recently, much attention has been drawn to the application of tyrosinase inhibitors 
occurring crude drugs to medical application and cosmetics business. There are now a variety of 
compounds including use to inhibit melanin synthesis in order to deal with skin pigmentation and 
disorder disease. The inhibition of tyrosinase is one of the major strategies to treat 
hyper-pigmentation, as potentially drugs. Natural compounds are first used to inhibit mushroom 
tyrosinase enzyme activity, then progresses until the catalysis of melanin is affected. For developing 
the new targeting protein, human tyrosinase, we used the 3-D structures to run computer screening 
to identify possible inhibitors of the enzymes. We will also develop human fibroblast assay to 
measure the cell viability of the inhibitors. 
 
Key words: Tyrosinase, melanocyte, structure, Cu, inhibition and mechanism. 
 
 Figure 1. Left, The cross-section of the epidermis. Right, Zoom in on the relationship between 
melanocyte and melanin. 
 
 
Figure 2. Pathway of melanin synthesis and the involved enzymes. 
 
Inhibition of tyrosinase 
Hyperpigmentation can be reduced and prevented in several ways like using ascorbic acid and 
its derivatives to chemical reduction of L-dopa to retard its oxidation into a chromophorous 
compound. Nevertheless, in this part I still take attention on tyrosinase inhibitor. It can be classed 
into three parts: (i) competitive inhibition, such as arbutin. (ii) cu2+ chelation, such as kojic acid (iii) 
Cytotoxicity to melanocytes, such as Hydroquinone. 
 
Materials and methods 
Form human tyrosinase recombinant protein 
The human tyrosinase gene will purchase from Bioresource Collection and Research Center, 
g1004038E04 (Hsinchu, Taiwan); NCBI, Accession No: BC027179. The primer (F) (Nde1):5' 
atattacatatgctgctggccgtgctgtac 3', primer (R) (Xho1):5' aaactcgagcaggtggctctggtacaggct 3', PCR mix 
(a mixture of DNA polymerase, reaction buffer, MgCl2, dNTP), The cloning vector is pET 20b 
(Figure 3), restriction enzyme 3`-NotI, 5`-SalI and the host is E. coli BL21 (DE3) codonplusRIL.  
spectrophotometrically based on the absorbance at 475 nm. 
 
Results  
 
0
25
50
75
100
Con
trol
Ko
jic 
acid PTU
α-
MS
H
200
 μ
M
100
 μ
M
50 
μM
10 
μM
Samples
Ce
ll v
ia
bi
lit
y (
%
 of
 co
nt
ro
l)
MAT 15
 
Fig. 2. HEMn-MP cell viability with various doses of (-)-N-formylanonaine. Kojic acid and PTU 
were used as melanin inhibitors at 100 M, and -MSH was melanin simulator at 0.1 M. 
Operation procedures were in Methods.  
 
0
25
50
75
100
Con
trol
Ko
jic 
acid PTU
α-
MS
H
200
 μ
M
100
 μ
M
50 
μM
10 
μM
Samples
Ty
ro
si
na
se
 ac
ti
vi
ty
 (%
 of
 co
nt
ro
l)
MAT 15
**
**
** **
**
*
a
 
200 without staining. Red arrows showed the HEMn-MP cells with bipolar shape morphology.  
 
 
References 
Kobayashi, T.; Urabe, K.; Winder, A. J.; Jiménez-Cervantes, C.; Imokawa, G.; Brewington, T. EMBO J, 1994, 13, 
5818–5825  
Lin, H.C., Shieh, B.H., Lu, M.H., Chen, J.Y., Chang, L.T., Chao, C.F., 2008. A method for quantifying melanosome 
transfer efficacy from melanocytes to keratinocytes in vitro. Pigment cell & melanoma research 21, 559-564. 
Likhitwitayawuid, K. and B. Sritularak, ‘‘A New Dimeric Stilbene with Tyrosinase Inhibitiory Activity from Artocarpus 
gomezianus,’’ J. Nat. Prod., 64, 1457 (2001). 
Maeda, K.; Fukuda, M. J Pharmacol Exp Ther, 1996, 276(2),765-769 
Maeda, K.; Yokokawa, Y.; Hatao, M.; Naganuma, M.; Tomita, Y. Journal of Dermatological Science, 1997, 14, 
199–206. 
Obinata, A.; Akimoto, Y.; Kawamata, T.; Shimizu, S.; Hirano, H.. Anat Rec, 1996 , 245(4), 715-23 
Sturm, R.A.; Box N.F. ; Ramsay, M. BioEssays, 1998, 20, 712–721.  
Yoshimura, K., Tsukamoto, K., Okazaki, M., Virador, V.M., Lei, T.C., Suzuki, Y., Uchida, G., Kitano, Y., Harii, K., 2001. 
Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of 
melanocytes. Journal of dermatological science Suppl 1, S68-75. 
 
 
(SCI, IF: 0.468; Ranks: Chemistry & Organic 51/55, 92.73%) 
9. Chien-Chih Chiu, Hsueh-Wei Chang, Da-Wei Chuang, Fang-Rong Chang, Yu-Ching Chang, 
Yu-Shan Cheng, Ming-Tz Tsai, Wan-Yu Chen, Su-Shuo Lee, Chih-Kuang Wang, Jeff Yi-Fu 
Chen, Hui-Min Wang, Chao-Chieh Chen, Yin-Chang Liu*, Yang-Chang Wu* 
Fern plant-derived protoapigenone leads to DNA damage, apoptosis and G2/M arrest in lung 
cancer cell line H1299 
DNA and Cell Biology. Vol. 28, No. 10, 501–506. 2009, 
(SCI, IF: 1.988; Ranks: Biochemistry & Molecular biology, 179/276, 64.86%). 
10. Chung-Yi Chen, Pei-Yu Wu, Tsi-Shu Huang, Chen-Wu Lin, Yi-Chi Li, Ruey-Hwang Chou, 
Hsueh-Wei Chang and Hui-Min Wang* 
The sour taste-modifying protein (miraculin), tyrosinase inhibitors and antioxidants from 
Synsepalum dulcificum 
Current Nutrition & Food Science. Vol. 5, No. 2, 172–179. 2009, (SCI) 
11. Bing-Hung Chen, Pei-Yu Wu, Kuan-Ming Chen, Tzu-Fun Fu, Hui-Min Wang*, and Chung-Yi 
Chen * 
Antiallergic Potential on RBL-2H3 Cells of Some Phenolic Constituents of Zingiber officinale 
(Ginger) 
Journal of Natural Products. 72, 950–953, 2009.  
(SCI, IF: 2.843; Ranks: Chemistry & Applied 4/60, 6.67%) 
12. Hui-Min Wang, Wen-Li Lo, Lee-Yu Huang, Yau-Der Wang and Chung-Yi Chen* 
Chemical Constituents from the leaves of Michelia alba 
2008, Vol. 23, in press. Natural Product Research. 
(SCI, IF: 0.782; Ranks: Chemistry & Applied 35/60, 58.33%) 
13. Chung-Yi Chen, Ching-Hsein Chen, Yi-Ching Lo, Bin-Nan Wu, Hui-Min Wang, Wen-Li Lo, 
Chuan-Min Yen and Rong-Jyh Lin* 
Anticancer Activity of Isoobtusilactone A from Cinnamomum kotoense: Involvement of 
Apoptosis, Cell-cycle Dysregulation, Mitochondria-regulation and Reactive Oxygen Species 
Journal of Natural Products, 71, 933-940, 2008 
(SCI, IF: 2.843; Ranks: Chemistry & Applied 4/60, 6.67%) 
14. Chung-Yi Chen, Po-Lin Kuo, Woei-Ling Yang Chau-Zen Wang, and Hui-Min Wang*, 
“Anticancer (human melanoma) proliferation activities of Synsepalum dulcificum 
extracts.” –2009, 美容科技學刊自然科學類第六卷第一期第 6-1A-3 篇 (p. 23-32) 
 
技術特點 
 
我們同時完成人類皮膚細胞與活體實驗，結果顯示兩種純化合物
皆可個別有效地抑制酪胺酸酶活性與黑色素生成量，且不具細胞
毒殺性。 
 
推廣及運用的價值 
 
化粧品、保養品、醫療用品 
※ 1.每項研發成果請填寫一式二份，一份隨成果報告送繳本會，一份送 貴單位研
發成果推廣單位（如技術移轉中心）。 
※ 2.本項研發成果若尚未申請專利，請勿揭露可申請專利之主要內容。 
※ 3.本表若不敷使用，請自行影印使用。 
